Exhibit 3
Financings By Type ($m)
Sanofi signed a $2bn deal with DiCE Molecules to develop small molecules against targets previously addressed by biologics; Toshiba sold its diagnostics and medical imaging division to Canon for $6bn. Debt offerings dominated biopharma and device financings.
Exhibit 3
Financings By Type ($m)